-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Enveric Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2017 to Q2 2024.
- Enveric Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $369K, a 55.3% decline year-over-year.
- Enveric Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $1.41M, a 40.8% decline year-over-year.
- Enveric Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.99M, a 17.5% decline from 2022.
- Enveric Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.42M, a 80.4% decline from 2021.
- Enveric Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $12.3M.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)